Filing Flows

Filing Flows › 8-K events › GE HealthCare Technologies

GE HealthCare Technologies: results of operations

Form 8-K filed Oct 28, 2026 · items 2.02, 5.02

Results of operationsGE HealthCare reports third quarter 2026 financial results

What the filing says

GE HealthCare reports third quarter 2026 financial results • Delivers top- and bottom-line growth ahead of Company expectations and raises full-year 2026 guidance

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Item 5.02: −0.1% next session across 39,174. Every item ranked →

What this kind of filing means

Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.

GE HealthCare Technologies at a glance

Latest quarterQ3 2026
Revenue$5.5B
Revenue Y/Y+7%
Operating margin14.6%
IndustryX-Ray Apparatus & Tubes & Related Irradiation Apparatus

GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%. The chart follows the revenue to costs, profit and cash.

GE HealthCare Technologies: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent guidance

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.